These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37485797)

  • 1. Association of serum brain-derived neurotrophic factor level and early response to antipsychotic drug in first-episode patients with schizophrenia.
    Zhao T; Tang S; Gao X; Li J; Hao R; Chen H; Huang G
    Int J Methods Psychiatr Res; 2023 Jul; 33(1):e1982. PubMed ID: 37485797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Risperidone and Paliperidone on Brain-Derived Neurotrophic Factor and N400 in First-Episode Schizophrenia.
    Wu RQ; Lin CG; Zhang W; Lin XD; Chen XS; Chen C; Zhang LJ; Huang ZY; Chen GD; Xu DL; Lin ZG; Zhang MD
    Chin Med J (Engl); 2018 Oct; 131(19):2297-2301. PubMed ID: 30246715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased serum brain-derived neurotrophic factor levels following electroconvulsive therapy or antipsychotic treatment in patients with schizophrenia.
    Li J; Ye F; Xiao W; Tang X; Sha W; Zhang X; Wang J
    Eur Psychiatry; 2016 Aug; 36():23-8. PubMed ID: 27311104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between the improvement in depressive symptoms and serum BDNF levels in drug-naive first episode patients with schizophrenia: A longitudinal follow-up.
    Han D; Sun D; Xiu M; Su X; Wang J; Li J; Wang D
    Psychoneuroendocrinology; 2021 Nov; 133():105392. PubMed ID: 34428640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BDNF serum levels and cognitive improvement in drug-naive first episode patients with schizophrenia: A prospective 12-week longitudinal study.
    Wu ZW; Shi H; Chen DC; Chen S; Xiu MH; Zhang XY
    Psychoneuroendocrinology; 2020 Dec; 122():104879. PubMed ID: 33049658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain-derived neurotrophic factor serum and plasma levels in the treatment of acute schizophrenia with olanzapine or risperidone: 6-week prospective study.
    Kudlek Mikulic S; Mihaljevic-Peles A; Sagud M; Bajs Janovic M; Ganoci L; Grubisin J; Kuzman Rojnic M; Vuksan Cusa B; Bradaš Z; Božina N
    Nord J Psychiatry; 2017 Oct; 71(7):513-520. PubMed ID: 28671000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum brain-derived neurotrophic factors in Taiwanese patients with drug-naïve first-episode schizophrenia: Effects of antipsychotics.
    Chiou YJ; Huang TL
    World J Biol Psychiatry; 2017 Aug; 18(5):382-391. PubMed ID: 27643618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Depressive Symptoms and Serum Brain-Derived Neurotrophic Factor Levels in Patients With First-Episode and Drug-Naïve Schizophrenia.
    Wu Y; Du X; Yang R; Yue Y; Peng R; Wu S; Wang H; Zhou Y; Fang X; Yuan N; Li R; Zhang J; Zou S; Zhao X; Lyu X; Li Z; Zhang X; Zhang X
    Front Psychiatry; 2022; 13():911384. PubMed ID: 35757201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased plasma brain-derived neurotropic factor, not nerve growth factor-Beta, in schizophrenia patients with better response to risperidone treatment.
    Lee BH; Kim YK
    Neuropsychobiology; 2009; 59(1):51-8. PubMed ID: 19270464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superoxide Dismutase, BDNF, and Cognitive Improvement in Drug-Naive First-Episode Patients With Schizophrenia: A 12-Week Longitudinal Study.
    Wu Z; Liu Q; Zhang Y; Guan X; Xiu M; Zhang X
    Int J Neuropsychopharmacol; 2022 Feb; 25(2):128-135. PubMed ID: 34622272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low serum levels of brain-derived neurotrophic factor in patients with schizophrenia do not elevate after antipsychotic treatment.
    Pirildar S; Gönül AS; Taneli F; Akdeniz F
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jul; 28(4):709-13. PubMed ID: 15276697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between BDNF levels and risperidone-induced weight gain is dependent on the BDNF Val66Met polymorphism in antipsychotic-naive first episode schizophrenia patients: a 12-week prospective study.
    Liu J; Wang P; Sun L; Guan X; Xiu M; Zhang X
    Transl Psychiatry; 2021 Sep; 11(1):458. PubMed ID: 34482368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased serum BDNF levels in chronic institutionalized schizophrenia on long-term treatment with typical and atypical antipsychotics.
    Xiu MH; Hui L; Dang YF; Hou TD; Zhang CX; Zheng YL; Chen DC; Kosten TR; Zhang XY
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1508-12. PubMed ID: 19720106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain-derived neurotrophic factor as a biomarker for cognitive recovery in acute schizophrenia: 12-week results from a prospective longitudinal study.
    Zhang Y; Fang X; Fan W; Tang W; Cai J; Song L; Zhang C
    Psychopharmacology (Berl); 2018 Apr; 235(4):1191-1198. PubMed ID: 29392373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BDNF in antipsychotic naive first episode psychosis: Effects of risperidone and the immune-inflammatory response system.
    Noto MN; Maes M; Vargas Nunes SO; Ota VK; Cavalcante D; Oliveira G; Rossaneis AC; Verri WA; Cordeiro Q; Belangero SI; Gadelha A; Noto C; Bressan RA
    J Psychiatr Res; 2021 Sep; 141():206-213. PubMed ID: 34246975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain-derived neurotrophic factor (BDNF) levels in first-episode schizophrenia and healthy controls: A comparative study.
    Singh J; Verma R; Raghav R; Sarkar S; Sood M; Jain R
    Asian J Psychiatr; 2020 Dec; 54():102370. PubMed ID: 33271690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex differences in the association between serum BDNF and cognitive impairment in schizophrenia patients using various antipsychotics.
    Dong R; Zhao NO; Wu HE; Yu L; Zhang XY
    J Psychiatr Res; 2021 Jun; 138():492-499. PubMed ID: 33971483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased levels of serum brain-derived neurotrophic factor in drug-naïve first-episode schizophrenia: relationship to clinical phenotypes.
    Chen DC; Wang J; Wang B; Yang SC; Zhang CX; Zheng YL; Li YL; Wang N; Yang KB; Xiu MH; Kosten TR; Zhang XY
    Psychopharmacology (Berl); 2009 Dec; 207(3):375-80. PubMed ID: 19787338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of serum BDNF and val66met polymorphism of the brain-derived neurotrophic factor in a sample of first psychotic episode patients.
    Rizos EN; Siafakas N; Stefanis N; Douzenis A; Kontaxakis V; Laskos E; Kastania A; Zoumbourlis V; Lykouras L
    Psychiatriki; 2009 Oct; 20(4):297-304. PubMed ID: 22218230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between the brain-derived neurotrophic factor Val66Met polymorphism and therapeutic response to olanzapine in schizophrenia patients.
    Nikolac Perkovic M; Nedic Erjavec G; Zivkovic M; Sagud M; Uzun S; Mihaljevic-Peles A; Kozumplik O; Muck-Seler D; Pivac N
    Psychopharmacology (Berl); 2014 Sep; 231(18):3757-64. PubMed ID: 24595507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.